Amanda F. Austin

For more than 20 years, Amanda Austin has provided sophisticated strategic counsel on transactions involving many of the life sciences industry’s most important emerging technologies. Her practice includes a full range of life sciences transactions, including co-development and co-commercialization licensing and collaboration arrangements, research and development collaboration agreements, strategic licensing partnerships, joint ventures, co-promotion relationships, and complex distribution and manufacturing arrangements. She also advises on intellectual property-related matters related to M&A transactions in the life sciences industry.

Amanda represents and counsels multinational pharmaceutical companies, biotechnology and synthetic biology companies, startups and early-stage enterprises, medical device companies, nonprofit organizations, and academic institutions in transactions critical to their business and mission, including innovatively structured deals and cross-border transactions.